BenevolentAI, an artificial intelligence biotech firm, has announced a reorganization to return to its original mission of serving biopharma industry partners. The changes include a refocus on core technologies for drug discovery and development.

 The company has further backing from renowned UK entrepreneurs, including health tech success stories Tania Boler, CEO and Founder of Elvie; Dr. Jean Nehme, Co-Founder of Digital Surgery; and Sachin Dev Duggal, Founder of Builder.ai. “We draw on ancient wisdom and modern science, learning from the world’s leading experts, to guide people with the knowledge, skills, and tools to mitigate stress,” says the company in the press release.

BenevolentAI Reorganizes to Refocus on Serving Biopharma Industry Partners

BenevolentAI Reorganizes to Refocus on Serving Biopharma Industry Partners

Company Info

Related People